Back

Loss of the H4 lysine methyltransferase KMT5B drives tumorigenic phenotypes by depleting H3K27me3 at loci otherwise retained in H3K27M mutant DIPG cells

Kessler, K.; Mackay, A.; Grabovska, Y.; Molinari, V.; Burford, A.; Temelso, S.; Tari, H.; Yara-Romero, E.; Liu, I.; Yu, L.; Castel, D.; Choudhary, J.; Sottoriva, A.; Filbin, M.; Vinci, M.; Jones, C.

2021-07-19 cancer biology
10.1101/2021.07.19.452493 bioRxiv
Show abstract

DIPG are characterised by histone H3K27M mutations, resulting in global loss of the repressive mark H3K27me3, although certain key loci are retained. We recently identified subclonal loss-of-function mutations in the H4 lysine methyltransferase KMT5B to be associated with enhanced invasion/migration, but the mechanism by which this occurred was unclear. Here we use integrated ChIP-seq, ATAC-seq and RNA-seq on patient-derived, subclonal and CRISPR-Cas9-KD DIPG cells to show that loss of KMT5B/C causes depletion of these retained H3K27me3 loci via changes in chromatin accessibility, causing a raft of transcriptional changes which promote tumorigenesis. De-repression occurred at bivalent loci marked by H3K4me3, driving increased transcriptional heterogeneity and elevated gene expression associated with increased invasion, abrogated DNA repair and mesenchymal transition, along with a markedly altered secretome. These data suggest a previously unrecognised trans-histone (H4/H3) interaction in DIPG cells with a potentially profound effect on their diffusely infiltrating phenotype.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cell Reports
○ 1498 papers in training set
Top 0.4%
17.9%
Similar papers in this journal
2
Nature Communications
○ 5641 papers in training set
Top 16%
11.5%
Similar papers in this journal
3
eLife
● 5828 papers in training set
Top 19%
6.5%
Similar papers in this journal
4
Cell
○ 431 papers in training set
Top 2%
5.3%
Similar papers in this journal
5
Molecular Cell
○ 350 papers in training set
Top 1%
4.7%
Similar papers in this journal
6
Cancer Discovery
● 66 papers in training set
Top 0.6%
4.7%
50% of probability mass above
7
Nature
○ 645 papers in training set
Top 4%
4.2%
8
Cancer Cell
○ 42 papers in training set
Top 0.4%
3.1%
9
Molecular Systems Biology
○ 162 papers in training set
Top 0.9%
2.6%
10
Nature Cell Biology
○ 118 papers in training set
Top 1%
2.6%
11
The EMBO Journal
○ 309 papers in training set
Top 2%
2.4%
12
Genes & Development
● 90 papers in training set
Top 0.6%
2.3%
13
Nature Genetics
○ 286 papers in training set
Top 3%
2.0%
14
Cell Stem Cell
○ 62 papers in training set
Top 0.8%
2.0%
15
Science Advances
● 1243 papers in training set
Top 19%
1.8%
16
Cell Genomics
○ 172 papers in training set
Top 2%
1.8%
17
Cancer Research
● 130 papers in training set
Top 2%
1.8%
18
Genome Biology
○ 637 papers in training set
Top 6%
1.6%
19
Developmental Cell
○ 196 papers in training set
Top 2%
1.6%
20
Journal of Experimental Medicine
● 119 papers in training set
Top 2%
1.4%
21
Cell Reports Medicine
○ 153 papers in training set
Top 3%
1.4%
22
iScience
○ 1154 papers in training set
Top 23%
1.4%
23
Genome Medicine
○ 183 papers in training set
Top 4%
1.1%
24
EMBO Reports
○ 263 papers in training set
Top 6%
1.0%
25
Genome Research
● 468 papers in training set
Top 7%
0.8%
26
PLOS Genetics
● 862 papers in training set
Top 12%
0.8%
27
JCI Insight
● 277 papers in training set
Top 9%
0.6%
28
Communications Biology
○ 993 papers in training set
Top 37%
0.6%
29
Science
● 477 papers in training set
Top 11%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.